Toronto Dominion Bank’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-4,000
Closed -$168K 1403
2021
Q1
$168K Hold
4,000
﹤0.01% 1103
2020
Q4
$280K Hold
4,000
﹤0.01% 993
2020
Q3
$113K Buy
4,000
+2,000
+100% +$65.1K ﹤0.01% 996
2020
Q2
$59K Hold
2,000
﹤0.01% 1057
2020
Q1
$40K Buy
+2,000
New +$50.4K ﹤0.01% 1059

Other funds holding EDIT

Toronto Dominion Bank's EDIT Position: Q2 2021 in Review

Toronto Dominion Bank sold out of Editas Medicine (EDIT) in Q2 2021, closing a stake of 4,000 shares — an estimated $168K sold.

Toronto Dominion Bank first reported a position in EDIT in Q1 2020 and held it in 5 quarters. The position peaked at $280K in Q4 2020. 313 funds tracked by Wall St. Rank hold EDIT as of Q2 2021.

  • Toronto Dominion Bank reported no remaining Editas Medicine position as of Q2 2021 after selling out during the quarter.
  • Toronto Dominion Bank sold 4,000 Editas Medicine shares in Q2 2021, an estimated $168K.
  • Toronto Dominion Bank first reported a position in Editas Medicine in Q1 2020 and held it in 5 quarters.
  • Toronto Dominion Bank's Editas Medicine position peaked at $280K in Q4 2020.
  • 313 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2021.

Based on Toronto Dominion Bank's 13F filing for Q2 2021, filed 10 Aug 2021.